UID
MRTX

Union Investments & Development’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Union Investments & Development’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,800
Closed -$106K – 46
2023
Q4 		$106K Hold
1,800
– – 0.1% 32
2023
Q3 		$78.4K Hold
1,800
– – 0.04% 36
2023
Q2 		$65K Hold
1,800
– – 0.03% 40
2023
Q1 		$66.9K Hold
1,800
– – 0.04% 40
2022
Q4 		$96.1K Hold
1,800
– – 0.06% 38
2022
Q3 		$126K Hold
1,800
– – 0.06% 31
2022
Q2 		$121K Hold
1,800
– – 0.05% 30
2022
Q1 		$148K Buy
+1,800
New +$184K 0.05% 29

Other funds holding MRTX

S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Union Investments & Development's MRTX Position: Q1 2024 in Review

Union Investments & Development sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2024, closing a stake of 1,800 shares — an estimated $106K sold.

Union Investments & Development first reported a position in MRTX in Q1 2022 and held it in 8 quarters. The position peaked at $148K in Q1 2022. 2 funds tracked by Wall St. Rank hold MRTX as of Q1 2024.

  • Union Investments & Development reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Union Investments & Development sold 1,800 Mirati Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $106K.
  • Union Investments & Development first reported a position in Mirati Therapeutics, Inc. Common Stock in Q1 2022 and held it in 8 quarters.
  • Union Investments & Development's Mirati Therapeutics, Inc. Common Stock position peaked at $148K in Q1 2022.
  • 2 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Union Investments & Development's 13F filing for Q1 2024, filed 7 May 2024.